American Association of Zoo Veterinarians Infectious Disease Manual anamorph of vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification)

Animal Transmission Clinical Severity Treatment Prevention Zoonotic Group(s) Signs and Control Affected -Direct Variable Mild to Itraconazole; Proper No direct -Indirect (via dermatitis; severe but Voriconazole, disinfection of transmission fomites and Cellulitis high Terbinafine housing areas; from environmental and edema mortality (nebulization/ avoid contamination) may be is possible SQ implants/ contaminated reported but present. injection) fomites; humans can Internal prevent be infected organ contact with invasion infected with O. animals ophidiicola Fact Sheet compiled by: E. Marie Rush Sheet completed on: updated 1 May 2018 Fact Sheet Reviewed by: Bonnie Raphael, Tim Georoff Susceptible groups: Reptiles Causative organism: Nannizziopsis spp., Ophidiomyces spp., Paranannizziopsis spp. Formerly, this grouping was Chrysosporium anamorph of Nannizziopsis vriesii (CANV) . Recent taxonomic publications have identified new epidemiological information about these fungi grouped under the CANV appellation. While Nannizziopsis vriesii does produce a Chrysosporium anamorph in culture, all CANV-like isolates differ so that an overarching CANV appellation is discouraged. For example, the “CANV” isolates that caused fatal disease in tentacled have been reclassified as two of Paranannizziopsis, which has not been isolated from other species. Paranannizziopsis includes four species that infect squamates and tuataras. Ophidiomyces (belonging to the Order ) is a potent pathogen of snakes and associated with “ Fungal Disease,” but it has not yet been recovered from ill lizards or crocodiles so may not be a threat to these taxa. Nannizziopsis guarroi is the main causative agent of “Yellow Fungus Disease,” a common infection in bearded dragons, green iguanas, and other lizards. Classically dermatomycoses in reptiles are linked with stress and substandard husbandry in captive animals however experimental challenge of veiled chameleons (Chamaeleo calyptratus) with Nannizziopsis dermatitidis confirmed the organism can act as a primary pathogen. Zoonotic potential: While it is not directly transmitted from animals to humans, infection has been reported in two human cases where pre-existing immunosuppression was present. There are multiple subspecies of reptile infective organisms. Human species of these organisms have not been recovered in reptiles. Distribution: Worldwide. Incubation period: 2-5 weeks Clinical signs: Infection is often through a breach in the skin. Ophidiopmyces is the likely causative agent of “Snake Fungal Disease”, however the two have not always been found in tandem. Slow progression occurs from dry, hyperkeratotic plaques or vesicles to exudative lesions with excessive crusting that may later darken and slough. Snakes with Ophidiomyces, may have increased ecdysis frequency, abnormal resting in areas of the enclosure and anorexia. Skin may have fissures or thickening and upon pressure or incision into these areas, exudate may be expelled. Cellulitis can present concurrently. In advanced disease, general debilitation of the animal may be noted and deeper tissues – including muscle and bone – become affected. Hemogram and chemistry panels may be normal during this infection. In pygmy rattlesnakes, corticosterone levels were proportionately increased in direct correlation with severity of clinical SFD, recapture, decreased reproduction in females and decreased body condition score. Clinical signs correlated American Association of Zoo Veterinarians Infectious Disease Manual Chrysosporium anamorph of Nannizziopsis vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification) with decreased environmental temperatures have been established for SFD. Paranannizziopsis australasiensis has been reported in a tuatara with clinical signs and positive testing on PCR. Post mortem, gross, or histologic findings: Initially, there will be hyphae proliferating in the epidermis (stratum corneum) with subsequent deeper invasion in most cases. Progression to liquefactive necrosis of the epidermis with or without granulomatous inflammation of the dermis is noted over time. Terminal chains of arthroconidia may be seen on hyphae, and with Ophidiomyces, granulocytic change at sites of microinvasion. Diagnosis: Clinical signs are suggestive. Fungal culture of the organism on Mycosel™ Agar with incubation at 25-28°C. Histopathology can be performed. PAS stained sections of tissues will reveal hyphae in the keratin layer, epidermis, dermis and occasionally skeletal muscle layers depending on severity of disease. Fungus can be identified by PCR. Although Taqman RT PCR and PCR are considered the most sensitive and specific of the diagnostic tests, not all tissues may be positive, even if grossly visible lesions are present. In a study with O. ophiodiicola, 98% of culture positive (and 40% of culture negative) snakes were found to be positive on RT-PCR. Of these snakes, 20 showed clinical signs and 16 had no clinical signs of infection. This study suggests that some asymptomatic snakes (~6%) may harbor low levels of fungus, and PCR paired with histopathology is recommended for definitive diagnosis. Massasaugas in Illinois with Ophiodiomyces showed changes in WBC counts, lymphocytes and basophils noted retrospectively over peak years. Material required for laboratory analysis: Frozen and formalin-fixed representative tissue samples from multiple organ systems (including skin, muscle, and bone) of necropsy specimens. Biopsies from live animals should be divided and submitted chilled for culture and fixed for histopathology. Relevant diagnostic laboratories: Most diagnostic laboratories are capable of culturing of this organism. Pre-emptive contact with microbiologist prior to sample submission greatly increases the chance of diagnosis. Treatment: Itraconazole and voriconazole can be used systemically. Terbinafine (10mg/kg PO SID x 7 days; pulse repeat Q3wk until one-week past resolution of signs) pulsed with itraconazole or voriconazole. In a study with timber rattlesnakes and massasaugas, voriconazole via SQ pump led to adequate levels in timber rattlesnakes, but not massasaugas. Levels post injection in cottonmouths were maintained for 12-24 hours. Cloacal administration in cottonmouths did not reach adequate levels, and several snakes died after a single injection without further treatment. In cottonmouths, terbinafine reached peak concentrations at 0.5-4 hours post nebulization, and on day 1using subcutaneous implants (which maintained therapeutic levels for over 6 weeks). Although topical disinfection of skin lesions with chlorhexidine solution may be helpful, alone it is not likely to be successful so combined approach is needed. Cutaneous lesions can be debrided aggressively along with topical antifungal and antibacterial dressings. Mycetomas should be considered for surgical excision in addition to systemic treatment. Prognosis for deeper structure involvement (e.g., bone) is guarded to poor. Prevention and control: Optimization of husbandry conditions is critical for most reptiles to prevent disease as the problem is exacerbated by suboptimal husbandry. Housing areas should be thoroughly disinfected between individuals and any porous material from the enclosures should be discarded if unable to be sterilized or properly disinfected (i.e. substrate, drift wood furniture, etc). Proper quarantine measures for new animals should be followed. Separation of infected animals from healthy animals should be done until infection is completely cleared, based on biopsies and culture. Suggested disinfectant for housing facilities: Bleach and chlorhexidine for CANV. For Ophidiomyces: 3% bleach for at least 2 minutes, 70% ethanol, 0.16% Roccal®-D for 10 minutes, Lysol® products, CLR® bath and kitchen cleaner (5-10% lactic acid), Process NPD® or Formula 409® household cleaners. Chlorhexidine, Simple Green® and spectracide are NOT effective for Ophidiomyces. Ten minutes of contact time is recommended for most cleaners to reach optimal spore removal. Notification: None required American Association of Zoo Veterinarians Infectious Disease Manual Chrysosporium anamorph of Nannizziopsis vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification)

Measures required under the Animal Disease Surveillance Plan: None required Measures required for introducing animals to infected animal: It is not recommended to introduce non- infected animals to infected animals until confirmation that infection is completely cleared based on culture of biopsy of the originally affected areas. Conditions for restoring disease-free status after an outbreak: It must be assured no residual carrier animals in remaining group of animals. Experts who may be consulted: Jean A. Paré, DMV, DVSc, DACZM Associate Veterinarian Global Health Program Wildlife Conservation Society 2300 Southern Boulevard Bronx, NY, 10460, USA Tel: 718-741-1174 Fax: 718-220-7126 Email: [email protected]

Matt Allender, DVM, MS, PhD, Dipl. ACZM Director, Wildlife Epidemiology Lab Assistant Professor College of Veterinary Medicine University of Illinois 3846 VMBSB 2001 S. Lincoln Ave., Urbana, IL 61802 Tel: 217-265-0320 Email: [email protected] References: 1. Abarca ML, Martorell J, Castellá G, Ramis A, Cabañes FJ. Cutaneous hyalohyphomycosis caused by a Chrysosporium species related to Nannizziopsis vriesii in two green iguanas (Iguana iguana). Med Mycol. 2008;46:349-354. 2. Allender MC, Hileman ET, Moore J, Tetzlaff S. Detection of Ophidiomyces, the causative agent of snake fungal disease, in the eastern massasauga (Sistrurus catenatus) in Michigan, USA, 2014. J Wildl Dis. 2016;52(3):694-8. 3. Allender MC, Phillips CA, Baker SJ, Wylie DB, Narotsky A, Dreslik MJ. Hematology in an eastern massasauga (Sistrurus catenatus) population and the emergence of Ophidiomyces in Illinois, USA. J Wildl Dis. 2016;52(2):258-69. 4. Bertelsen MF, Crawshaw GJ, Sigler L, Smith DA. Fatal cutaneous mycosis in tentacled snakes (Erpeton tentaculatum) caused by the Chrysosporium anamorph of Nannizziopsis vriesii. J Zoo Wildl Med. 2005;36: 82-87. 5. Bohuski E, Lorch JM, Griffin KM, Blehert DS. TaqMan real-time polymerase chain reaction for detection of Ophidiomyces ophiodiicola, the fungus associated with snake fungal disease. BMC Vet Res. 2015;11:95. 6. Bowman MR, Paré JA, Sigler L, Naeser JP, Sladky KK, Hanley CS, Helmer P, Phillips LA, Brower A, Porter R. Deep fungal dermatitis in three inland bearded dragons (Pogona vitticeps) caused by the Chrysosporium anamorph of Nannizziopsis vriesii. Med Mycol. 2007;45: 371-376. 7. Eatwell K. Suspected fatal Chrysosporium anamorph of Nannizziopsis vriesii (CANV) dermatitis in an albino boa constrictor (Constrictor constrictor). J Small Anim Pract. 2010;51(5):290. American Association of Zoo Veterinarians Infectious Disease Manual Chrysosporium anamorph of Nannizziopsis vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification)

8. Franklinos LH, Lorch JM, Bohuski E, Fernandez JR, Wright ON, Fitzpatrick L, Petrovan S, Durrant C, Linton C, Baláž V, Cunningham AA. Emerging fungal pathogen Ophidiomyces ophiodiicola in wild European snakes. Sci Rep. 2017;19;17(1):3384. 9. Guthrie AL, Knowles S, Balimann AE Lorch JM. Detection of snake fungal disease due to Ophidiomyces ophiodiicola in Virginia, USA. J Wildl Dis. 2016;52(1):143-9. 10. Hellebuyck T, Baert K, Pasmans F, Van Waeyenberghe L, Beernaert L. Chiers K, De Backer P, Haesebrouck F, Martel A. Cutaneous hyalohyphomycosis in a girdled lizard (Cordylus giganteus) caused by the Chrysosporium anamorph of Nannizziopsis vriesii and successfully treated with voraconizole. Vet Derm. 2010;21(4):429-433. 11. Hill AJ, Leys JE, Bryan D, Erdman FM, Malone KS, Russell GN, Applegate RD, Fenton H, Niedringhaus K, Miller AN, Allender MC. Common cutaneous bacteria isolated form snakes inhibit growth of Ophidiomyces ophiodiicola. Ecohealth. 2018;15(1):109-120. 12. Humphrey S, Alexander S, Ha HJ. Detection of Paranannizziopsis australasiensis in tuatara (Sphenodon punctatus) using fungal culture and a generic fungal PCR. N Z Vet J. 2016;64(5):298- 300. 13. Johnson RS, Sangster CR, Sigler L, Hambleton S, Paré JA. Deep fungal dermatitis caused by the Chrysosporium anamorph of Nannizziopsis vriesii in captive coastal bearded dragons (Pogona barbata). Aust Vet J. 2011;89(12):515-519. 14. Johnson DH. An emerging dermatomycosis and systemic mycosis syndrome in bearded dragons. Exotic DVM 2004;6.3:75-77. 15. Kane LP, Allender MC, Archer G, Leister K, Rzadkowska M, Boers K, Souza M, Cox S. Pharmacokinetics of nebulized and subcutaneously implanted terbinafine in cottonmouths (Agkistrodon piscivorus). J Vet Pharmacol Ther. 2017;40(5):575-579. 16. Last LA, Fenton H, Gonyor-McGuire J, Moore M, Yabsley MJ. Snake fungal disease caused by Ophidiopmyces ophiodiicola in a free-ranging mud snake (Farancia abacura). J Vet Diagn Invest. 2016;28(6):709-713. 17. Lind CM, McCoy CM, Farrell TM. Tracking outcomes of snake fungal disease in free-ranging pygmy rattlesnakes (Sistrurus miliarius). J Wildl Dis. 2018;54(2):352-356. 18. Lind C, Moore IT, Akçay Ç, Vernasco BJ, Lorch JM, Farrell TM. Patterns of circulating corticosterone in a population of rattlesnakes afflicted with snake fungal disease: stress hormones as a potential mediator of seasonal cycles in disease severity and outcomes. Physiol Biochem Zool. 2018;91(2):765-775. 19. Lindemann, D.M., Allender, M.C., Rzadkowska, M., Archer, G., Kane, L., Baitchman, E., Driskell, E.A., Chu, C.T., Singh, K., Hsiao, S.H. and Sykes IV, J.M. Pharmacokinetics, efficacy, and safety of voriconazole and itraconazole in healthy cottonmouths (Agkistrodon piscivorus) and massasauga rattlesnakes (Sistrutus catenatus) with snake fungal disease. J Zoo Wildl Med. 2017;48(3):757-766. 20. Lorch JM, Knowles S, Lankton JS, Michell K, Edwards JL, Kapfer JM, Staffen RA, Wild ER, Schmidt KZ, Ballmann AE, Blodgett D. 2016. Snake fungal disease: an emerging threat to wild snakes. Philos Trans R Soc Lond B Biol Sci. 2016;371(1709). 21. Lorch JM, Lankton J, Werner K, Falendysz EA, McCurley K, Blehert DS. Experimental infection of snakes with Ophidiomyces ophiodiicola causes pathological changes that typify snake fungal disease. MBio. 2015;6(6). 22. McCoy CM, Lind CM, Farrell TM. Environmental and physiological correlates of the severity of clinical signs of snake fungal disease in a population of pygmy rattlesnakes (Sistrurus miliarus). Conserv Physiol. 2017;5(1). 23. Mitchell MA, Walden MR. Crysosporium anamorph Nannizziopsis vriesii: an emerging fungal pathogen of captive and wild reptiles. Vet Clin North Am Exot Anim Pract: 2013;16(3):659-68. American Association of Zoo Veterinarians Infectious Disease Manual Chrysosporium anamorph of Nannizziopsis vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification)

24. Nichols, D.K., R.S. Weyant, E.W. Lamirande, L. Sigler, and R.T. Mason. 1999. Fatal mycotic dermatitis in captive brown tree snakes (Boiga irregularis). J. Zoo Wildl. Med. 30: 111-118. 25. Ohkura, M., R.R. Fitak, J.H. Wisecaver, et al. 2017. Genome sequence of Ophidiomyces ophiodiicola, an emerging fungal pathogen of snakes. Genome Announc. Jul 27;5(30). 26. Ohkura, M., J.J. Worley, J.E. Hughes-Hallett, et al. 2016. Ophidiomyces ophiodiicola on a captive black racer (Coluber constrictor) and a garter snake (Thamnophis sirtalis) in Pennsylvania. J Zoo Wildl Med. Mar;47(1):341-6. 27. Paré, J.A. and L. Sigler. 2016. An overview of reptile fungal pathogens in the Genera Nannizziopsis, Paranannizziopsis, and Ophidiomyces. J Herp Med Surg, 26(1-2):46-53 28. Paré, J., and E.R. Jacobson. 2007. Mycotic diseases of reptiles. In: Jacobson, E.R. (ed.). Infectious Diseases and Pathology of Reptiles. CRC Press, Boca Raton, Florida. Pp. 527-570. 29. Paré, J.A., K.A. Coyle, L. Sigler, A.K. Maas, III, and R.L. Mitchell. 2006. Pathogenicity of the Chrysosporium Anamorph of Nannizziopsis vriesii for veiled chameleons (Chamaeleo calyptratus). Med. Mycol. 44: 25-31. 30. Paré, J.A., L. Sigler, K.L. Rosenthal, and D.R. Mader. 2006. Microbiology: fungal and bacterial diseases of reptiles. In: Mader, D.R. (ed.). Reptile Medicine and Surgery, 2nd ed. Saunders Elsevier, St. Louis, Missouri. Pp: 217-238. 31. Paré, J.A., L. Sigler, K.L. Rypien, and C.F.C. Gibas. 2003. Cutaneous mycobiota of captive squamate reptiles with notes on the scarcity of Chrysosporium anamorph of Nannizziopsis vriesii. J. Herpetol. Med. Surg. 13: 10-15. 32. Paré, J.A., L. Sigler, D.B. Hunter, R.C. Summerbell, D.A. Smith, and K.L. Machin. 1997. Cutaneous mycoses in chameleons caused by the Chrysosporium anamorph of Nannizziopsis vriesii (Apinis) Currah. J. Zoo. Wildl. Med. 28: 443-453. 33. Picquet, P., K.O> Heckers, E. Kolesnik, A Heusinger and R.E. Marchang. Detection of Ophidiomyces ophiodiicola in two captive Bocourt water snakes (Subsessor bocourti) and one captive Pueblan mild snake (Lampropeltis trangulum campbelli). 2018. J Zoo Wildl Med. Mar;49(1):219-222. 34. Robertson, J., S.K. Chinnadurai, D.B. Woodburn, M.J. Adkesson and J.A. Landolfi. 2016. Disseminiated Ophidiomyces ophiodiicola infection in a captive eastern Massasauga (Sistrurus catenatus catenatus). J Zoo Wildl Med. Mar;47(1):337-40. 35. Rzadkowska, M., M.C. Allender, M. O’Dell and C. Maddox. 2016. Evaluation of common disinfectants effective against Ophidiomyces ophiodiicola, the causative agent of snake fungal disease. J Wildl Dis. Jul;52(3):759-62. 36. Sigler, L., S. Hambleton, S. and J.A. Paré. Molecular characterization of reptile pathogens currently known as members of the Chrysosporium anamorph of Nannizziopsis vriesii complex and relationship to some human associated isolates. 2013. J Clin Microbiol. Oct;51(10):3338-57. 37. Steininger, C., J. van Lunzen, K. Tintelnot, I. Sobottka, H. Rohde, M. Ansver Horstkotte, and H.J. Stellbrink. 2005. Mycotic brain abscess caused by opportunistic reptile pathogen. Emerg Infect Dis 11: 349-350. 38. Thomas, A. D., L. Sigler, S. Peucker, J.H. Norton, and A. Nielan. 2002. Chrysosporium anamorph of Nannizziopsis vriesii associated with fatal cutaneous mycoses in the salt-water crocodile (Crocodylus porosus). Med Mycol. 40: 143-151. 39. Toplon, D.E., S.P. Terrell, L. Sigler, and E.R. Jacobson. 2013. Dermatitis and cellulitis in leopard geckos (Eublepharis macularius) caused by the Chrysosporium anamorph of Nannizziopsis vriesii. Vet Pathol. 50(4): 585-9. 40. Van Waeyenberghe, L., K. Baert, F. Pasmans, P. van Rooij P, T. Hellebuyck, L. Beernaert, P. de Backer, F. Haesebrouck, and A. Martel. 2010. Voriconazole, a safe alternative for treating infections American Association of Zoo Veterinarians Infectious Disease Manual Chrysosporium anamorph of Nannizziopsis vriesii: Nannizziopsis, Paranannizziopsis, and Ophiodiomyces ophidiicola (Under reclassification) caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps). Med Mycol. 48(6): 880-885.